Candida orthopsilosis에 의한 치명적 진균혈증 1예 = A Fatal Case of Candida orthopsilosis Fungemia

다국어 초록 (Multilingual Abstract)

Candida orthopsilosis is a recently described Candida species phenotypically indistinguishable from Candida parapsilosis. This new species can be identified only by using molecular methods. We describe here a fatal case of fungemia caused by C. orthopsilosis in a 75-year-old male patient who had panperitonitis after total gastrectomy with Roux-en-Y esophagojejunostomy.
All 18 blood cultures obtained from admission day 16 to day 68 yielded the same Candida species. Both Vitek 2 (bioMerieux, Inc., Hazelwood,MO, USA) and API 20C (bioMerieux, Marcy-l'Etoile,France) failed to identify these isolates. However,DNA sequencing analysis of both D1/D2 domain and internal transcribed spacer region of rDNA showed 100% identity with C. orthopsilosis. The fungemia was persistent over 50 days despite of systemic antifungal therapy including fluconazole and caspofungin,and the patient expired on day 73 of his hospital stay. This represents the first reported case of fatal fungemia by C. orthopsilosis in Korea. (Korean J Clin Microbiol 2010;13:140-143)

참고문헌 (Reference)

1 Nucci M, "Revisiting the source of candidemia: skin or gut?" 33 : 1959-1967, 2001

2 Silva AP, "Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital" 47 : 2392-2397, 2009

3 Gomez-Lopez A, "Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain" 52 : 1506-1509, 2008

4 Kocsube S, "Occurrence and genetic variability of Candida parapsilosis sensu lato in Hungary" 56 : 190-195, 2007

5 Tay ST, "Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections" 58 : 185-191, 2009

6 Shin JH, "Microevolution of Candida albicans strains during catheter-related candidemia" 42 : 4025-4031, 2004

7 Tavanti A, "Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients" 45 : 1455-1462, 2007

8 Brielmaier BD, "Early clinical experience with anidulafungin at a large tertiary care medical center" 28 : 64-73, 2008

9 Song JW, "Differences in biofilm production by three genotypes of Candida parapsilosis from clinical sources" 43 : 657-661, 2005

10 Cheung C, "Development of candidemia on caspofungin therapy: a case report" 34 : 345-348, 2006

11 van Asbeck EC, "Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typingand antimicrobial susceptibility" 35 : 283-309, 2009

12 Tavanti A, "Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III" 43 : 284-292, 2005

13 Kim MN, "Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features" 48 : 57-61, 2009

14 Shin JH, "Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources" 40 : 1244-1248, 2002